Protalix BioTherapeutics, Inc. (PLX) |
|---|
| $0.26 52 Week Low | $0.93 2017-04-28 14:49:51 MDT | $1.51 52 Week High |
| Healthcare Sector | Biotechnology Industry |
| NYSE Stock Exchange | Israel Country |
| Market Cap: | $128,970,000 | Micro Cap (Less than $200M) |
| Analyst Recommendation: | 1.5 | Analysts say: Strong Buy. (1=Strong Buy, 5=Strong Sell) |
| Beta: | 1.2 | Higher Volatility Stock (beta over 1). Stock will go up more when the market goes up, and go down more when the market goes down. Beta of 1 means stock would match the S&P 500 Index. |
ForwardPE: Unknown | 5 Yr Est Growth: 25.00% | Yield: 0.00% |
PEG-Y Ratio: N/A | Unknown PEG-Y ratio |
% Above 50 DayMA: -21.19% | % Above 200 DayMA: 27.40% |
PLX Performance 52 Weeks: 19.54% | S&P 500 Performance 52 Weeks: 13.50% |
Mixed Trend. Short Term trend is down, but longer term trend is up. There is hope because 50 Day MA is still above 200 Day MA. Stock is closer to 52 Week High than 52 Week Low. | PLX outperforming S&P 500 by 6.04% the last 52 Weeks. |
Price To Book: N/A | Unknown Price to Book Ratio |
EV to EBITDA: -4.52 | Unknown EV to EBITDA ratio |
| Field | Value | Average | Comments |
|---|---|---|---|
| % Held By Insiders | 13.90% | 17.28% | Held by fewer than average Insiders. |
| % Held By Institutions | 31.30% | 62.07% | Institutional percentage lower than average. Institutions may not have conviction in stock. Or is this a chance for institutions to invest more and boost price? |
| Short % Of Float | N/A | 07.02% | Unknown. |
| Debt to Equity | N/A | 1.08 | Unknown. |
| Profit Margin % | N/A | -00.18% | Unknown. |
| Operating Margin % | -360.51% | -05.28% | Operating Margin less than average percent. Stock can do better than this? |
| Return on Equity % | -6.00% | -08.79% | Return on Equity greater than average percent. Good. |
| Return on Assets % | -23.09% | -01.29% | Return on Assets less than average percent. Stock can do better than this? |
| Revenue Per Employee | $39,655.17 | $883,096.70 | Less than average Revenue Per Employee. This stock (or industry) might not be as efficient as others? Each industry might have a different standard. |
| Price to Cash | 1.82 | 5.52 | Lower than average Price to Cash. Meaning that the company has a higher percentage of cash as a percent of price. Cash can be good to cushion company during hard times, and as a potential source for buyouts or investments. However, some activists want the cash to be used by a company to buy its own stock, or to increase their dividend, or to invest the money. |
| CPEGY Ratio | N/A | 2.26 | Unknown. |
PROS:
| CONS:
|